The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.
RSS Feed for InvestorBrandNetwork (IBN)October 9, 2025 — Wall Street giant Morgan Stanley has encouraged investors to consider allocating between 2% and 4% of their portfolios to cryptocurrencies. The bank’s latest recommendation marks a notable shift in Wall Street’s tone toward digital assets, with Bitcoin taking the spotlight as a limited-supply asset often compared to gold in digital form.
October 9, 2025 — The world of finance is changing fast, and one of the biggest shifts coming is tokenization. Both Wall Street and the crypto industry believe that turning real-world assets like stocks, bonds, and funds into digital tokens will completely reshape how global markets work.
October 9, 2025 — The Trump administration has scrapped $7. 6 billion in clean energy grants, singling out projects located exclusively in states that supported Kamala Harris in the 2024 election.
October 9, 2025 — Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) a mineral exploration company, reported additional assay results from step-out holes DSB-88 and DSB-89 in the Silver-Zinc-Polymetallic Domain of its Santa Barbara starter pit area at the Iska Iska Project, confirming continued mineralization open to the east. The results include 1.
October 9, 2025 — Datavault AI (NASDAQ: DVLT), a leader in AI-driven data visualization, valuation, and monetization, announced a strategic partnership with leading Southwest U. S.
October 8, 2025 — High employee turnover can hurt any company, but it’s especially tough in the marijuana business, where skilled workers are needed everywhere—from the dispensary counter to the cultivation room. As competition grows and margins tighten, keeping reliable, knowledgeable staff is not just an advantage; it’s what keeps a business running.
October 8, 2025 — Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is focused on the development of the world-class platinum group metal Waterberg deposit in South Africa. “Platinum and palladium are quietly becoming important to modern defense technology.
October 8, 2025 — HeartBeam (NASDAQ: BEAT) is on the verge of revolutionizing cardiac diagnostics with its groundbreaking ECG technology. A recent article discussing this reads, “HeartBeam plans to initiate commercialization immediately upon receiving FDA clearance.
October 8, 2025 — Fairchild Gold (TSX-V: FAIR) has signed a Memorandum of Understanding to acquire a 100% interest in the Golden Arrow Project, an advanced-stage gold property located along Nevada’s Walker Lane Shear Zone. As reported in an article by Ryan D.
October 8, 2025 — NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, has re-filed an Abbreviated New Drug Application (“ANDA”) for KETAFREE(TM), a preservative-free intravenous (“IV”) ketamine formulation intended for all currently approved ketamine indications. This follows FDA approval of NRx’s Suitability Petition… KETAFREE(TM) is designed to eliminate benzethonium chloride (“BZT”), a known neurotoxic and cytotoxic preservative still present in many ketamine formulations.
October 8, 2025 — Audius, the largest decentralized music discovery and marketplace platform, announced that verified artists can now create their own Solana-based crypto coins directly on the platform—marking a major step toward transforming traditional fan clubs into dynamic, tokenized communities. In just minutes, artists can mint branded coins to reward fans with access to exclusive music, private Discord channels, app-wide badges, and direct messages.
October 8, 2025 — NextPlat (NASDAQ: NXPL, NXPLW), a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels, issued a shareholder update detailing operational progress and strategic initiatives for the remainder of 2025. Interim CEO Charles M.
October 8, 2025 — OptimumBank’s Q2 2025 earnings reached $3. 6 million, with deposits growing at a double-digit annualized pace.
October 8, 2025 — ESGold (CSE: ESAU) (OTCQB: ESAUF) announced that its geological and engineering team has arrived in Colombia to begin on-the-ground validation and due diligence at the Planta Magdalena Project, following the memorandum of understanding signed Aug. 20, 2025.
October 8, 2025 — Izotropic Corp. marks a significant milestone in breast imaging with its patent-pending personalized radiation dose feature with the IzoView Breast CT system Recently, the company secured a $375,000 non-brokered private placement to help with core operations in addition to engaging new PR partners for improved investor communications With projections for global breast imaging expected to hit $8.
October 8, 2025 — TransCode Therapeutics (NASDAQ: RNAZ) announced it has entered into a definitive agreement to acquire Polynoma LLC, a privately held immuno-oncology company developing seviprotimut-L, a late-stage polyvalent shed antigen vaccine for the adjuvant treatment of stage IIB and IIC melanoma. Concurrent with the acquisition, TransCode secured a $25 million investment from CK Life Sciences Int’l (Holdings) Inc.
October 8, 2025 — Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM), a biopharmaceutical company advancing innovative treatments for neurodegenerative, metabolic, and alcohol misuse disorders, announced the implementation of a public whistleblower policy offering cash rewards of up to USD $7 million for verifiable evidence of stock manipulation involving the Company’s shares. Eligible participants may submit information directly to reward@quantumbiopharma.
October 8, 2025 — Railtown AI Technologies (CSE: RAIL) (OTCQB: RLAIF), a leader in Canadian-built artificial intelligence solutions, announced that it has entered into an amalgamation agreement to acquire all issued and outstanding shares of AI Partnerships Corp. (AIP) through a three-cornered amalgamation, making AIP a wholly owned subsidiary of Railtown.
October 8, 2025 — Oncotelic Therapeutics developed the Deciparticles(TM) technology to improve the bioavailability of drugs, largely thanks to the creation of sub-20nm size of the nanoparticles Sapu Nano, part of Oncotelic’s GMP Bio joint venture, receives clearance to begin Phase 1 trial of Sapu003, an injectable form of Everolimus (Afinitor(R)) for breast cancer In preclinical studies, Sapu003 could raise the bioavailability of Everolimus (Afinitor(R)) from around 10%, as oral pill, up to anywhere from 80 to 100%, as injectable Result hopes for higher bioavailability in that drugs may have dramatically better, faster, and more consistent efficacy for patients Oncotelic Therapeutics (OTCQB: OTLC) is a clinical-stage biopharmaceutical company advancing a diversified pipeline spanning oncology, immunotherapy, neurodegeneration, and rare diseases. In a recent interview on the BioMedWire podcast, Chairman and CEO Dr.
October 8, 2025 — Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company developing imaging-based technologies for more accurate breast cancer screening, diagnosis, and treatment, marked Breast Cancer Awareness Month by emphasizing the limitations of current imaging tools and the significant opportunity for its flagship IzoView Breast CT Imaging System. With more than 2.